These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6254427)

  • 1. [Epidermodysplasia verruciformis (2 cases). Immunological study (author's transl)].
    Guilhou JJ; Malbos S; Barnéon S; Habib A; Baldet P; Meynadier J
    Ann Dermatol Venereol; 1980 Jul; 107(7):611-9. PubMed ID: 6254427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human papillomavirus and oncogenesis (author's transl)].
    Jabłońska S
    Z Hautkr; 1982 Apr; 57(8):551-66. PubMed ID: 6283752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New developments relating to papillomaviruses].
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Obalek S; Rzesa G; Croissant O; Favre M
    Hautarzt; 1979 Aug; 30(8):411-7. PubMed ID: 229087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus?
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Rzesa G; Obałek S; Glinski W; Favre M; Croissant O
    J Invest Dermatol; 1979 Mar; 72(3):114-9. PubMed ID: 217936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel human papillomavirus identified in epidermodysplasia verruciformis.
    Harris AJ; Purdie K; Leigh IM; Proby C; Burge S
    Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies in epidermodysplasia verruciformis.
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Rzesa G; Obalek S; Glinski W; Favre M; Croissant O
    Bull Cancer; 1978; 65(2):183-90. PubMed ID: 212145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis.
    Lutzner MA
    Bull Cancer; 1978; 65(2):169-82. PubMed ID: 212144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IgE and cellular immunity in cutaneous lymphomas (author's transl)].
    Guilhou JJ; Clot J; Robinet-Lévy M; Meynadier J
    Ann Dermatol Venereol; 1977; 104(8-9):533-7. PubMed ID: 303883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of mucosal human papilloma virus DNA in bowenoid papulosis, Bowen's disease and squamous cell carcinoma of the skin.
    Hama N; Ohtsuka T; Yamazaki S
    J Dermatol; 2006 May; 33(5):331-7. PubMed ID: 16700665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressed immune function in epidermodysplasia verruciformis.
    Prawer SE; Pass F; Vance JC; Greenberg LJ; Yunis EJ; Zelickson AS
    Arch Dermatol; 1977 Apr; 113(4):495-9. PubMed ID: 848981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Warts, viruses, cancer (author's transl)].
    Pruniéras M
    Ann Dermatol Venereol; 1978 May; 105(5):479-83. PubMed ID: 213005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion.
    Majewski S; Jablonska S
    Cancer Res; 1997 Oct; 57(19):4214-6. PubMed ID: 9331078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two siblings with epidermodysplasia verruciformis with large clear cells in the epidermis: electron microscope and immunological findings.
    Feuerman EJ; Sandbank M; David M
    Acta Derm Venereol; 1979; 59(6):513-20. PubMed ID: 94210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic potential of human papillomaviruses epidermodysplasia verruciformis: a counterpart of Shope papilloma-carcinoma complex.
    Jabłonska S; Orth G; Obalek S; Croissant O; Jarzabek-Chorzelska M; Favre M; Kremsdorf D
    Arch Geschwulstforsch; 1983; 53(3):207-15. PubMed ID: 6311135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papilloma viruses, warts, carcinoma and Langerhans cells.
    Viac J; Chardonnet Y; Chignol MC; Schmitt D
    In Vivo; 1993; 7(3):207-12. PubMed ID: 8395234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seborrheic Keratosis-like lesions in patients with epidermodysplasia verruciformis.
    Roncalli de Oliveira W; Neto CF; Rady PL; Tyring SK
    J Dermatol; 2003 Jan; 30(1):48-53. PubMed ID: 12598709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-one years of follow-up studies of familial epidermodysplasia verruciformis.
    Jabłońska S; Orth G; Jarzabek-Chorzelska M; Gliński W; Obałek S; Rzesa G; Croissant O; Favre M
    Dermatologica; 1979; 158(5):309-27. PubMed ID: 220107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Report of a case without immune dysfunction. Effect of treatment with an aromatic retinoid.
    Claudy AL; Touraine JL; Mitanne D
    Arch Dermatol Res; 1982; 274(3-4):213-9. PubMed ID: 6299205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
    Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
    Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.